Question 1

What kind of company is Kosei Pharmaceutical Co., Ltd.?

Accepted Answer

A:Kosei Pharmaceutical Co., Ltd. is a premier Japanese pharmaceutical wholesaler and specialized trading house established in 1952. With over 70 years of history, the company is a global leader in supplying high-quality Japanese pharmaceuticals to the international market.Corporate Profile & Strategic StrengthsCore Business Integration: Combines a robust domestic foundation (trading with approx. 12,000 medical institutions in Japan) with an extensive global supply chain reaching over 50 countries.Proven Track Record: Maintains a vast network of over 70,000 corporate and medical partners worldwide.Specialized ExpertiseExporting Japanese-origin pharmaceuticals.Sourcing Orphan Drugs and Oncology medications.Operation of the global procurement platform 'synapse'.Corporate Governance: A wholly-owned subsidiary of Clinifer Co., Ltd. (Tokyo Stock Exchange: 432A). This ensures the highest standards of financial transparency and regulatory compliance.

Question 2

What kind of company is Kosei Pharmaceutical Co., Ltd.?

Accepted Answer

A:Kosei Pharmaceutical Co., Ltd. is a long-established Japanese pharmaceutical wholesaler and specialized trading house headquartered in Osaka, established in 1952. With over 70 years of heritage, the company is a global leader that integrates a robust domestic foundation with the cutting-edge digital platform, 'synapse.'Corporate Attributes & Core CompetenciesProven Reliability & Market Presence: As an independent wholesaler, we maintain a powerful network of approximately 12,000 medical institutions and pharmacies across Japan.Pioneer in Global Distribution: We operate 'synapse,' a proprietary cross-border platform designed to connect the Japanese pharmaceutical market with the world, serving as a vital bridge for the stable supply of high-quality medicines to global healthcare settings.Strong Governance & Financial Stability: As a wholly-owned subsidiary of Clinphar Inc. (Tokyo Stock Exchange: 432A), we operate with the highest standards of transparency and regulatory compliance required of a publicly-listed group.Specialized Supply Chain Capabilities: We offer optimized domestic and international logistics, specializing in rapid response to urgent medical needs and the handling of medications requiring strict GDP-compliant cold chain management.Corporate ProfileOfficial Name: Kosei Pharmaceutical Co., Ltd.Established: July 1952 (Over 70 years of operation)Headquarters: 5th Floor, OMM Building, 1-7-31 Otemae, Chuo-ku, Osaka, JapanPresident & CEO: Kohei TodaParent Company: Clinphar Inc. (TSE: 432A)

Question 3

Where can I access "My Account" to view or change my registered information and password?

Accepted Answer

A:The 'My Account' page is your central hub for managing your email address, password, and membership status. Please follow the steps below based on the device you are using.UI Navigation by DeviceFor Desktop (PC) UsersClick the 'Person/User Icon' (the furthest one on the right in the header icon row).From the dropdown menu or via the 'My Page' dashboard, select 'My Account.'For Mobile UsersTap the 'Hamburger Menu' (the three-line icon) in the top-left corner.Select 'My Account' (or the account settings within the 'My Page' menu) from the list.Key Management Features in 'My Account'Update Login Credentials: Change your registered email address (Login ID) or update your password to maintain account security.Membership Status: Review your current registration category, account permissions, and any applicable expiration dates.Notification Preferences: Manage how you receive automated system alerts and administrative emails.

Question 4

What is "synapse"? (https://synapse.net)

Accepted Answer

A:'synapse' is a specialized B2B platform for Japanese pharmaceutical information and procurement, operated by Kosei Pharmaceutical Co., Ltd. It serves as a digital bridge between the Japanese drug market and global healthcare professionals.Service Overview & Core FunctionsPharmaceutical Database:  A comprehensive, English-language database of Japanese medicines, searchable by Active Ingredient (USAN/INN), Therapeutic Class, or Manufacturer.Key FeaturesSearch & Research:  Accurate, professional-grade research for Japanese pharmaceutical products.Request for Quote (RFQ):  Fast quotation generation via the 'My List' feature.One-Stop Procurement:  Seamless transition from information browsing to secure online ordering for registered members.Target AudienceSpecifically designed for overseas medical professionals, including Doctors, Pharmacists, Hospitals, and Licensed Pharmaceutical Wholesalers.

Question 5

What specific features and functions are available on "synapse"?

Accepted Answer

A:'synapse' provides an advanced, end-to-end digital ecosystem that streamlines the entire process from pharmaceutical research to procurement.Core Features & WorkflowPrecision Search Engine:  Enables pinpoint product identification through multi-dimensional filtering, including Active Ingredient (USAN/INN), Therapeutic Category, Manufacturer, and specialized tags.Streamlined Quotation Process (RFQ)'My List' Integration: Easily add required products to a centralized interest list.One-Click Request: Submit a free quotation request directly from your list.Fast Turnaround: Receive an accurate official quotation within as little as 2 business days.Digital Order Management:  Seamlessly transition from quotation approval to final order placement and real-time progress tracking-all within the platform.Personalized Dashboard:  A dedicated member portal to manage transaction history and optimize the monitoring of frequently sourced products.

Question 6

What are PMDA Standards, and what specific requirements do they include?

Accepted Answer

A:'PMDA Standards' is a collective term for the regulations and guidelines established by the Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labour and Welfare (MHLW). These standards are designed to ensure the Quality, Efficacy, and Safety of all pharmaceuticals and medical devices distributed within Japan.Structural Understanding of the Regulatory FrameworkPMDA Standards encompass a comprehensive set of rules covering the entire product lifecycle:Standards for Manufacturing and Quality Control (GxP):GMP (Good Manufacturing Practice): Standards for manufacturing control and quality control of products.GQP (Good Quality Practice): Standards for quality control of the marketing authorization holder (MAH).Benchmarks for Approval and Conformity Assessment:The Japanese Pharmacopoeia (JP): The official compendium of standards for the properties and quality of drugs.Essential Principles: Requirements regarding the safety and performance that medical devices must satisfy.Individual Approval/Certification Standards: Specific review guidelines established for particular diseases or product categories.Post-Marketing Safety ManagementGVP (Good Vigilance Practice): Standards for post-marketing safety management to monitor adverse effects and ensure patient safety.Professional Advice for Importers and Sourcing PartnersConformity for the Japanese Market: When introducing overseas products to Japan, proof of conformity to these PMDA Standards is mandatory. In particular, the GMP Inspection of manufacturing facilities is a critical and rigorous step in the approval process.Tracking the Latest Updates: Standards and guidelines are frequently updated to align with scientific progress. For the latest review policies regarding a specific product, we recommend checking the official PMDA website or consulting our regulatory specialists via Messages.

synapse.FAQ

About synapse

Account

Features

RFQ

Payment

Logistics